STOCK TITAN
  1. Home
  2. Sec-filings
  3. CDIO
  4. [Form 4] Cardio Diagnostics Holdings, Inc. Insider Trading Activity

Cardio Diagnostics (CDIO) director receives 2,854 stock options at $2.19 strike

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Cardio Diagnostics Holdings, Inc. director Peter K. Fung received a grant of stock options as part of his compensation. On June 30, 2026, he was awarded 2,854 stock options with a conversion price of $2.19 per share, each option representing the right to buy one share of common stock. These are classified as a grant or award, not an open-market purchase or sale. Following this award, Fung holds a total of 12,367 stock options linked to Cardio Diagnostics common stock, giving him additional potential future ownership if he chooses to exercise the options before they expire in 2036.

Positive

  • None.

Negative

  • None.
Insider Fung Peter K
Role null
Type Security Shares Price Value
Grant/Award Stock Options (Right to Buy) 2,854 $2.19 $6K
Holdings After Transaction: Stock Options (Right to Buy) — 12,367 shares (Direct, null)
Footnotes (1)
Options granted 2,854 options Stock options award on June 30, 2026
Exercise price $2.19 per share Conversion or exercise price for granted options
Total options after grant 12,367 options Total stock options held following this transaction
Option expiration June 30, 2036 Expiration date of the granted stock options
Stock Options (Right to Buy) financial
"security_title: Stock Options (Right to Buy)"
Grant, award, or other acquisition financial
"transaction_code_description: Grant, award, or other acquisition"
Common Stock financial
"underlying_security_title: Common Stock"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Fung Peter K
(Last)(First)(Middle)
311 W. SUPERIOR ST., SUITE 444
C/O CARDIO DIAGNOSTICS HOLDINGS, INC.
(Street)
CHICAGO ILLINOIS 60654
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
Cardio Diagnostics Holdings, Inc. [ CDIO ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)Other (specify below)
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
06/30/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Options (Right to Buy)$2.1906/30/2026A2,85406/30/202606/30/2036Common Stock2,854$2.1912,367D
Explanation of Responses:
/s/Elisa Luqman as attorney-in-fact for Peter Fung07/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did Cardio Diagnostics (CDIO) director Peter K. Fung report in this Form 4?

Peter K. Fung reported receiving a grant of 2,854 stock options for Cardio Diagnostics common stock. This is a compensation-related award, not a market trade, and increases his potential future ownership if he exercises the options.

How many Cardio Diagnostics (CDIO) stock options did Peter K. Fung receive and at what price?

Peter K. Fung received 2,854 stock options with a conversion or exercise price of $2.19 per share. Each option represents the right to buy one share of Cardio Diagnostics common stock at that price in the future.

What is Peter K. Fung’s total option position in Cardio Diagnostics (CDIO) after this grant?

After the grant, Peter K. Fung holds 12,367 stock options in total. This total includes the newly awarded 2,854 options and represents his potential future right to acquire Cardio Diagnostics common shares through option exercise.

Is the Cardio Diagnostics (CDIO) Form 4 for Peter K. Fung a stock purchase or sale?

The Form 4 reflects a grant or award acquisition of stock options, coded as transaction type “A.” It is not an open-market buy or sell of shares, but a compensation-related option award from the company.

When do Peter K. Fung’s new Cardio Diagnostics (CDIO) stock options expire?

The newly granted 2,854 stock options for Cardio Diagnostics common stock have an expiration date of June 30, 2036. Fung may choose to exercise these options before that date at the fixed price of $2.19 per share.